BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Collegium Pharmaceutical, Inc. 

400 Highland Corporate Drive

Cumberland  Rhode Island  02864  U.S.A.
Phone: 401-762-2000 Fax: 401-762-2043


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Collegium Pharmaceutical, Inc. Announces Issuance Of U.S. Patent Covering Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Opioid Product 7/2/2014 10:56:14 AM
Collegium Pharmaceutical, Inc. Advances Development Program For Hydrocodone DETERx(R), An Abuse-Deterrent, Extended-Release Analgesic for the Treatment of Chronic Pain 5/30/2014 9:04:13 AM
Collegium Pharmaceutical, Inc. To Present At The Jefferies and Co. 2014 Global Healthcare Conference In New York On June 3, 2014 5/27/2014 9:11:51 AM
Collegium Pharmaceutical, Inc.'s CEO To Present At The UBS 2014 Global Healthcare Conference In New York On May 21, 2014 5/13/2014 9:49:10 AM
Collegium Pharmaceutical, Inc. Announces Successful Pre-NDA Meeting With FDA For Oxycodone DETERx®, Its Extended-Release, Abuse-Deterrent Product For The Treatment Of Chronic Pain 4/29/2014 11:01:02 AM
Collegium Pharmaceutical, Inc. Announces Positive Topline Results Of Clinical Study Evaluating The Effect Of Crushing 4/2/2014 11:11:07 AM
Collegium Pharmaceutical, Inc. Announces Allowance Of New Claims Covering DETERx®, An Abuse-Deterrent, Extended-Release, Technology Platform 3/19/2014 10:09:30 AM
Collegium Pharmaceutical Announces Completion of Enrollment in Pivotal Phase 3 Clinical Study for Oxycodone DETERx(R), Its Lead Abuse-Deterrent Development Program 2/4/2014 9:50:41 AM
Collegium Pharmaceutical, Inc. Announces Positive Topline Results Of Human Abuse Potential Study Evaluating Intranasal Administration Of Crushed Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Product 1/15/2014 9:00:51 AM
Collegium Pharmaceutical, Inc. Announces Issuance of U.S. Patent and Allowance of New Claims Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product 10/17/2013 9:54:42 AM
1234567